IDX719

DRUG4 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Chronic Hepatitis C InfectionHepatitis C, Chronic

Phase 1

Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001)

CompletedNCT01508156

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2012-01-31End: 2012-07-31Updated: 2015-04-27

Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004)

CompletedNCT01813513

Merck Sharp & Dohme LLCChronic Hepatitis C Infection

Start: 2013-01-31End: 2013-07-31Updated: 2016-01-26

Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Participants (MK-1894-007)

CompletedNCT01907724

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2013-05-31End: 2013-08-31Updated: 2016-01-26

Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008)

CompletedNCT01919125

Merck Sharp & Dohme LLCHepatitis C, Chronic

Start: 2013-08-31End: 2014-02-28Updated: 2016-01-26